- Published on
Ophthalmology – Ectopia Lentis
Ectopia lentis refers to displacement of the crystalline lens from its normal position due to weakness or disruption of the zonular fibers. The condition may present as subluxation (partial displacement) or luxation (complete dislocation). It can occur as an isolated ocular finding or as part of systemic connective tissue or metabolic disorders, and may also result from trauma.
The condition is strongly associated with systemic diseases such as Marfan syndrome (where 60–75% of patients develop ectopia lentis) and homocystinuria (seen in 80–85% of cases). Other associations include Ehlers–Danlos syndrome, Weill–Marchesani syndrome, hyperlysinemia, sulfite oxidase deficiency, and congenital ocular anomalies. Trauma is also an important cause, particularly in unilateral cases. Genetically, ectopia lentis may be inherited in autosomal dominant or recessive patterns, often involving mutations in genes such as FBN1 (fibrillin) or ADAMTSL4, both critical for zonular integrity.
The underlying pathophysiology involves weakening, stretching, or rupture of the zonular fibers that suspend the lens. In connective tissue disorders like Marfan syndrome, abnormal fibrillin leads to fragile zonules, whereas in metabolic disorders like homocystinuria, defective cysteine metabolism weakens zonular structure. This results in progressive lens instability and displacement.
Patients may present with blurred vision, monocular diplopia, or fluctuating refractive error, depending on the degree of lens displacement. A history of trauma or systemic disease, or a family history, may be present. On examination, slit-lamp findings reveal decentered lens position, abnormal zonules (stretched, broken, or absent), and sometimes irregular lens edges. Additional findings may include corectopia (displaced pupil), elevated intraocular pressure, or signs of associated systemic disease.
Diagnostic evaluation includes a thorough ocular exam and systemic assessment. In patients without trauma or known diagnosis, serum or urine homocysteine levels should be checked due to the serious systemic risks of homocystinuria, including thromboembolism. Imaging such as echocardiography may be required when conditions like Marfan syndrome are suspected. Genetic testing may help confirm the diagnosis in selected cases.
Management depends on severity and underlying cause. Initial treatment focuses on optical correction with glasses or contact lenses and treatment of amblyopia, especially in children. In cases where the lens dislocates into the anterior chamber, urgent management is required to prevent pupillary block glaucoma, including medications such as mannitol, steroids, and mydriatics, along with positioning the patient supine.
Surgical treatment is indicated when vision cannot be corrected optically or when complications arise. This typically involves lensectomy with anterior vitrectomy, followed by visual rehabilitation using contact lenses or aphakic spectacles. In some cases, intraocular lens implantation may be considered, though this is often limited in children due to poor zonular support.
Regular follow-up is essential to monitor for progressive lens displacement, amblyopia, glaucoma, and retinal detachment, particularly in conditions like Marfan syndrome. Prognosis is generally good with early diagnosis and appropriate management, with many patients achieving visual acuity of 20/40 or better, provided complications are addressed promptly.
Ectopia lentis refers to displacement of the crystalline lens from its normal position due to weakness or disruption of the zonular fibers. The condition may present as subluxation (partial displacement) or luxation (complete dislocation). It can occur as an isolated ocular finding or as part of systemic connective tissue or metabolic disorders, and may also result from trauma.
The condition is strongly associated with systemic diseases such as Marfan syndrome (where 60–75% of patients develop ectopia lentis) and homocystinuria (seen in 80–85% of cases). Other associations include Ehlers–Danlos syndrome, Weill–Marchesani syndrome, hyperlysinemia, sulfite oxidase deficiency, and congenital ocular anomalies. Trauma is also an important cause, particularly in unilateral cases. Genetically, ectopia lentis may be inherited in autosomal dominant or recessive patterns, often involving mutations in genes such as FBN1 (fibrillin) or ADAMTSL4, both critical for zonular integrity.
The underlying pathophysiology involves weakening, stretching, or rupture of the zonular fibers that suspend the lens. In connective tissue disorders like Marfan syndrome, abnormal fibrillin leads to fragile zonules, whereas in metabolic disorders like homocystinuria, defective cysteine metabolism weakens zonular structure. This results in progressive lens instability and displacement.
Patients may present with blurred vision, monocular diplopia, or fluctuating refractive error, depending on the degree of lens displacement. A history of trauma or systemic disease, or a family history, may be present. On examination, slit-lamp findings reveal decentered lens position, abnormal zonules (stretched, broken, or absent), and sometimes irregular lens edges. Additional findings may include corectopia (displaced pupil), elevated intraocular pressure, or signs of associated systemic disease.
Diagnostic evaluation includes a thorough ocular exam and systemic assessment. In patients without trauma or known diagnosis, serum or urine homocysteine levels should be checked due to the serious systemic risks of homocystinuria, including thromboembolism. Imaging such as echocardiography may be required when conditions like Marfan syndrome are suspected. Genetic testing may help confirm the diagnosis in selected cases.
Management depends on severity and underlying cause. Initial treatment focuses on optical correction with glasses or contact lenses and treatment of amblyopia, especially in children. In cases where the lens dislocates into the anterior chamber, urgent management is required to prevent pupillary block glaucoma, including medications such as mannitol, steroids, and mydriatics, along with positioning the patient supine.
Surgical treatment is indicated when vision cannot be corrected optically or when complications arise. This typically involves lensectomy with anterior vitrectomy, followed by visual rehabilitation using contact lenses or aphakic spectacles. In some cases, intraocular lens implantation may be considered, though this is often limited in children due to poor zonular support.
Regular follow-up is essential to monitor for progressive lens displacement, amblyopia, glaucoma, and retinal detachment, particularly in conditions like Marfan syndrome. Prognosis is generally good with early diagnosis and appropriate management, with many patients achieving visual acuity of 20/40 or better, provided complications are addressed promptly.
- Published on
Ophthalmology – Eales Disease
Eales disease is an idiopathic obliterative retinal vasculopathy that primarily affects young adults, classically presenting with a triad of retinal phlebitis, peripheral retinal nonperfusion, and recurrent vitreous hemorrhage. It is considered a diagnosis of exclusion, meaning other causes of retinal vasculitis must be ruled out before confirming the condition.
The disease is most commonly reported in regions such as India and the Middle East, typically affecting individuals between 20 and 30 years of age. Earlier studies suggested a male predominance, but more recent data indicate a more equal gender distribution. A possible association with hypersensitivity to tuberculin protein has been proposed, and tubercle bacilli have occasionally been identified in pathological specimens, although the exact cause remains unclear.
Pathophysiologically, Eales disease involves a nonspecific inflammatory occlusive vasculitis, primarily affecting retinal veins. This leads to vascular inflammation (phlebitis), followed by capillary closure and ischemia, which in turn stimulates retinal neovascularization. These fragile new vessels are prone to bleeding, resulting in recurrent vitreous hemorrhage, a hallmark complication.
Patients commonly present with decreased vision, floaters, or “cobweb-like” visual disturbances, often due to vitreous hemorrhage. On examination, findings include retinal vascular sheathing, hemorrhages, and exudates along affected vessels. More than half of patients have bilateral involvement. Additional findings may include vitreous cells, cystoid macular edema, and neovascularization of the retina or optic disc, which can progress to neovascular glaucoma if untreated.
Diagnosis relies heavily on fluorescein angiography, which helps identify areas of retinal nonperfusion, vascular leakage, and neovascularization. Optical coherence tomography (OCT) may detect associated macular edema or epiretinal membranes. Since Eales disease is a diagnosis of exclusion, investigations are necessary to rule out other causes such as diabetes, sickle cell disease, retinal vein occlusion, inflammatory or infectious vasculitis, and systemic autoimmune conditions.
Management focuses on controlling complications. Panretinal photocoagulation (laser therapy) is essential in cases with retinal ischemia and neovascularization to prevent further hemorrhage and tractional complications. Corticosteroids, either systemic or intravitreal, may help reduce inflammation and vascular leakage. Anti-VEGF agents (such as bevacizumab) are sometimes used to induce regression of neovascularization. In advanced cases with persistent vitreous hemorrhage or tractional retinal detachment, vitrectomy surgery may be required.
Patients require regular follow-up every 3 to 12 months, depending on disease severity, to monitor for progression and complications. Education is important—patients should be aware of symptoms such as sudden floaters or vision loss, which may indicate vitreous hemorrhage.
The prognosis is generally favorable with appropriate management, with many patients maintaining visual acuity of 20/40 or better. However, complications such as recurrent vitreous hemorrhage, retinal detachment, and neovascular glaucoma can significantly impact vision if not treated promptly.
Eales disease is an idiopathic obliterative retinal vasculopathy that primarily affects young adults, classically presenting with a triad of retinal phlebitis, peripheral retinal nonperfusion, and recurrent vitreous hemorrhage. It is considered a diagnosis of exclusion, meaning other causes of retinal vasculitis must be ruled out before confirming the condition.
The disease is most commonly reported in regions such as India and the Middle East, typically affecting individuals between 20 and 30 years of age. Earlier studies suggested a male predominance, but more recent data indicate a more equal gender distribution. A possible association with hypersensitivity to tuberculin protein has been proposed, and tubercle bacilli have occasionally been identified in pathological specimens, although the exact cause remains unclear.
Pathophysiologically, Eales disease involves a nonspecific inflammatory occlusive vasculitis, primarily affecting retinal veins. This leads to vascular inflammation (phlebitis), followed by capillary closure and ischemia, which in turn stimulates retinal neovascularization. These fragile new vessels are prone to bleeding, resulting in recurrent vitreous hemorrhage, a hallmark complication.
Patients commonly present with decreased vision, floaters, or “cobweb-like” visual disturbances, often due to vitreous hemorrhage. On examination, findings include retinal vascular sheathing, hemorrhages, and exudates along affected vessels. More than half of patients have bilateral involvement. Additional findings may include vitreous cells, cystoid macular edema, and neovascularization of the retina or optic disc, which can progress to neovascular glaucoma if untreated.
Diagnosis relies heavily on fluorescein angiography, which helps identify areas of retinal nonperfusion, vascular leakage, and neovascularization. Optical coherence tomography (OCT) may detect associated macular edema or epiretinal membranes. Since Eales disease is a diagnosis of exclusion, investigations are necessary to rule out other causes such as diabetes, sickle cell disease, retinal vein occlusion, inflammatory or infectious vasculitis, and systemic autoimmune conditions.
Management focuses on controlling complications. Panretinal photocoagulation (laser therapy) is essential in cases with retinal ischemia and neovascularization to prevent further hemorrhage and tractional complications. Corticosteroids, either systemic or intravitreal, may help reduce inflammation and vascular leakage. Anti-VEGF agents (such as bevacizumab) are sometimes used to induce regression of neovascularization. In advanced cases with persistent vitreous hemorrhage or tractional retinal detachment, vitrectomy surgery may be required.
Patients require regular follow-up every 3 to 12 months, depending on disease severity, to monitor for progression and complications. Education is important—patients should be aware of symptoms such as sudden floaters or vision loss, which may indicate vitreous hemorrhage.
The prognosis is generally favorable with appropriate management, with many patients maintaining visual acuity of 20/40 or better. However, complications such as recurrent vitreous hemorrhage, retinal detachment, and neovascular glaucoma can significantly impact vision if not treated promptly.
- Published on
Ophthalmology – Dyslexia
Dyslexia is a primary reading disorder characterized by difficulty in acquiring accurate and fluent reading skills due to a language-processing abnormality in the brain. It is not caused by poor vision, low intelligence, lack of motivation, or inadequate teaching. Instead, dyslexia primarily results from a deficit in phonological processing, meaning difficulty in recognizing and manipulating the sounds of language. Historically referred to as “word blindness,” it is now well established that dyslexia is not a visual disorder, although children may appear to skip words or reverse letters due to underlying language-processing challenges.
Dyslexia is relatively common, affecting approximately 5–17% of children, with boys diagnosed more frequently than girls. It exists along a continuum of reading ability in the population, with dyslexia representing the lower end. There is a strong genetic component, with heritability estimated between 54–75%. It often runs in families, and multiple genetic loci have been identified, supporting a polygenic inheritance pattern.
The underlying pathophysiology involves abnormal activation of left hemisphere brain regions responsible for reading, particularly the temporoparietal and occipitotemporal areas. Individuals with dyslexia show reduced activity in these regions and may compensate by using alternative neural pathways, such as frontal brain regions. These differences highlight that dyslexia is a neurobiological disorder of language processing, not an ocular or visual tracking problem.
Clinically, younger children may present with language delay, difficulty learning letters, trouble with rhymes, or mispronouncing words. Older children often demonstrate slow, effortful reading, poor spelling, and a mismatch between their reading ability and overall intelligence. Importantly, children with dyslexia generally have normal eye health and visual function, and any abnormal eye movements observed are a consequence—not a cause—of reading difficulty.
Evaluation of suspected dyslexia includes hearing and vision screening to rule out contributing factors, followed by formal educational and neuropsychological testing. Diagnosis is made using standardized assessments of reading, phonological processing, and comprehension by trained specialists such as psychologists or educators. Imaging studies are not routinely required.
Management is centered on early, structured educational intervention, particularly focusing on phonological awareness and decoding skills. Early intervention (especially between ages 6–8) significantly improves outcomes. Older children benefit from academic accommodations, such as extra time, audiobooks, and assistive technology. It is important to note that vision therapy, eye exercises, and colored lenses have not been proven effective for treating dyslexia.
The prognosis is variable but generally reflects a chronic condition rather than a temporary delay. Without early intervention, reading difficulties often persist into adolescence and adulthood. However, with appropriate support and tailored instruction, many individuals with dyslexia can achieve strong academic and functional outcomes.
Dyslexia is a primary reading disorder characterized by difficulty in acquiring accurate and fluent reading skills due to a language-processing abnormality in the brain. It is not caused by poor vision, low intelligence, lack of motivation, or inadequate teaching. Instead, dyslexia primarily results from a deficit in phonological processing, meaning difficulty in recognizing and manipulating the sounds of language. Historically referred to as “word blindness,” it is now well established that dyslexia is not a visual disorder, although children may appear to skip words or reverse letters due to underlying language-processing challenges.
Dyslexia is relatively common, affecting approximately 5–17% of children, with boys diagnosed more frequently than girls. It exists along a continuum of reading ability in the population, with dyslexia representing the lower end. There is a strong genetic component, with heritability estimated between 54–75%. It often runs in families, and multiple genetic loci have been identified, supporting a polygenic inheritance pattern.
The underlying pathophysiology involves abnormal activation of left hemisphere brain regions responsible for reading, particularly the temporoparietal and occipitotemporal areas. Individuals with dyslexia show reduced activity in these regions and may compensate by using alternative neural pathways, such as frontal brain regions. These differences highlight that dyslexia is a neurobiological disorder of language processing, not an ocular or visual tracking problem.
Clinically, younger children may present with language delay, difficulty learning letters, trouble with rhymes, or mispronouncing words. Older children often demonstrate slow, effortful reading, poor spelling, and a mismatch between their reading ability and overall intelligence. Importantly, children with dyslexia generally have normal eye health and visual function, and any abnormal eye movements observed are a consequence—not a cause—of reading difficulty.
Evaluation of suspected dyslexia includes hearing and vision screening to rule out contributing factors, followed by formal educational and neuropsychological testing. Diagnosis is made using standardized assessments of reading, phonological processing, and comprehension by trained specialists such as psychologists or educators. Imaging studies are not routinely required.
Management is centered on early, structured educational intervention, particularly focusing on phonological awareness and decoding skills. Early intervention (especially between ages 6–8) significantly improves outcomes. Older children benefit from academic accommodations, such as extra time, audiobooks, and assistive technology. It is important to note that vision therapy, eye exercises, and colored lenses have not been proven effective for treating dyslexia.
The prognosis is variable but generally reflects a chronic condition rather than a temporary delay. Without early intervention, reading difficulties often persist into adolescence and adulthood. However, with appropriate support and tailored instruction, many individuals with dyslexia can achieve strong academic and functional outcomes.
- Published on
Ophthalmology – Duane Syndrome
Duane syndrome is a congenital eye movement disorder characterized primarily by limited abduction (outward movement of the eye), along with globe retraction and narrowing of the palpebral fissure on attempted adduction. It is classified into three types: Type I, the most common, shows marked limitation of abduction with relatively preserved adduction; Type II shows limitation of adduction with exotropia; and Type III involves limitation of both abduction and adduction. The condition is part of a group known as congenital cranial dysinnervation disorders, reflecting abnormal nerve supply to the extraocular muscles.
Duane syndrome accounts for about 1% of all strabismus cases and is more common in females, with unilateral involvement being more typical than bilateral. Risk factors include thalidomide exposure during early pregnancy and associations with certain congenital syndromes. Genetically, mutations in genes such as CHN1 and CPAH have been identified, usually with an autosomal dominant inheritance pattern, though many cases are sporadic.
The underlying pathophysiology involves absence or hypoplasia of the sixth cranial nerve (abducens nerve) and abnormal innervation of the lateral rectus muscle by the oculomotor nerve. This leads to co-contraction of medial and lateral rectus muscles, causing globe retraction and narrowing of the eyelid fissure during adduction. The characteristic upshoots and downshoots seen in some patients are thought to result from a mechanical “leash effect” or anomalous muscle innervation.
Clinically, children often present with an eye that does not move outward properly, sometimes associated with esotropia and a compensatory head turn (face turn) to maintain binocular vision. On examination, key findings include limited abduction, variable limitation of adduction, globe retraction on adduction, and vertical upshoots or downshoots. A full ocular exam is essential, particularly to assess for amblyopia, refractive error, and abnormal head posture. Some patients may also have associated ocular findings such as iris abnormalities, cataracts, or coloboma, as well as systemic associations like hearing loss.
Diagnosis is primarily clinical, though high-resolution MRI may demonstrate absence or abnormality of the sixth nerve. Audiologic evaluation is recommended in cases with suspected associated syndromes. The differential diagnosis includes sixth nerve palsy, congenital esotropia, and orbital restrictive conditions.
Management focuses on optimizing vision and alignment. Refractive errors and amblyopia must be treated first with glasses or occlusion therapy. Surgical intervention is considered when there is a significant deviation in primary gaze, abnormal head posture, or cosmetically significant globe retraction or up/down shoots. Surgical approaches typically involve recession of the medial or lateral rectus muscles, and in selected cases, muscle transposition procedures. Importantly, resection of the lateral rectus is generally avoided as it can worsen globe retraction.
The prognosis for vision is excellent if amblyopia is addressed early. While surgery can improve alignment and reduce abnormal head posture, it does not fully restore normal eye movements, particularly abduction. Long-term follow-up is important to monitor for amblyopia, recurrent strabismus, and head posture abnormalities.
Duane syndrome is a congenital eye movement disorder characterized primarily by limited abduction (outward movement of the eye), along with globe retraction and narrowing of the palpebral fissure on attempted adduction. It is classified into three types: Type I, the most common, shows marked limitation of abduction with relatively preserved adduction; Type II shows limitation of adduction with exotropia; and Type III involves limitation of both abduction and adduction. The condition is part of a group known as congenital cranial dysinnervation disorders, reflecting abnormal nerve supply to the extraocular muscles.
Duane syndrome accounts for about 1% of all strabismus cases and is more common in females, with unilateral involvement being more typical than bilateral. Risk factors include thalidomide exposure during early pregnancy and associations with certain congenital syndromes. Genetically, mutations in genes such as CHN1 and CPAH have been identified, usually with an autosomal dominant inheritance pattern, though many cases are sporadic.
The underlying pathophysiology involves absence or hypoplasia of the sixth cranial nerve (abducens nerve) and abnormal innervation of the lateral rectus muscle by the oculomotor nerve. This leads to co-contraction of medial and lateral rectus muscles, causing globe retraction and narrowing of the eyelid fissure during adduction. The characteristic upshoots and downshoots seen in some patients are thought to result from a mechanical “leash effect” or anomalous muscle innervation.
Clinically, children often present with an eye that does not move outward properly, sometimes associated with esotropia and a compensatory head turn (face turn) to maintain binocular vision. On examination, key findings include limited abduction, variable limitation of adduction, globe retraction on adduction, and vertical upshoots or downshoots. A full ocular exam is essential, particularly to assess for amblyopia, refractive error, and abnormal head posture. Some patients may also have associated ocular findings such as iris abnormalities, cataracts, or coloboma, as well as systemic associations like hearing loss.
Diagnosis is primarily clinical, though high-resolution MRI may demonstrate absence or abnormality of the sixth nerve. Audiologic evaluation is recommended in cases with suspected associated syndromes. The differential diagnosis includes sixth nerve palsy, congenital esotropia, and orbital restrictive conditions.
Management focuses on optimizing vision and alignment. Refractive errors and amblyopia must be treated first with glasses or occlusion therapy. Surgical intervention is considered when there is a significant deviation in primary gaze, abnormal head posture, or cosmetically significant globe retraction or up/down shoots. Surgical approaches typically involve recession of the medial or lateral rectus muscles, and in selected cases, muscle transposition procedures. Importantly, resection of the lateral rectus is generally avoided as it can worsen globe retraction.
The prognosis for vision is excellent if amblyopia is addressed early. While surgery can improve alignment and reduce abnormal head posture, it does not fully restore normal eye movements, particularly abduction. Long-term follow-up is important to monitor for amblyopia, recurrent strabismus, and head posture abnormalities.
- Published on
Infectious Disease and Microbiology - Measles
Measles is a highly contagious viral disease characterized by fever and a distinctive maculopapular rash that begins on the face and spreads downward to the trunk and extremities. The rash is typically preceded by a prodromal phase of cough, coryza, and conjunctivitis, along with the pathognomonic Koplik’s spots on the buccal mucosa. While often self-limited in healthy children, measles remains a major cause of morbidity and mortality, particularly in malnourished or immunocompromised populations.
Globally, measles continues to affect millions of individuals each year, with significant mortality despite widespread vaccination efforts. Although vaccination coverage has improved, outbreaks still occur, especially in low-income countries and in areas affected by conflict or poor healthcare access. Individuals at highest risk include those who are unvaccinated, immunocompromised, pregnant, malnourished, or at extremes of age. Healthcare workers without immunity are also at risk and may contribute to transmission.
The virus spreads via respiratory droplets and initially infects the respiratory mucosa before disseminating through lymphatic and hematogenous routes. It affects multiple organ systems including the skin, conjunctiva, lungs, and gastrointestinal tract. The appearance of the rash corresponds with the host immune response and marks the decline in viral transmissibility. The causative agent is the measles (rubeola) virus, an RNA virus of the Paramyxoviridae family.
Clinically, measles begins with a prodrome of high fever, cough, conjunctivitis, and coryza. Koplik’s spots—small white lesions on the buccal mucosa—appear early and are highly characteristic. This is followed by a red maculopapular rash that starts behind the ears and on the forehead, then spreads downward. The rash typically lasts about five days before fading, sometimes followed by desquamation. In partially immune individuals, atypical and milder presentations may occur.
Diagnosis is primarily clinical, based on characteristic signs and symptoms. Laboratory findings may include leukopenia, T-cell cytopenia, and thrombocytopenia. Serologic testing can confirm diagnosis in atypical cases. Chest imaging may reveal interstitial pneumonitis in severe disease. Viral detection can be performed using immunofluorescence or PCR from respiratory secretions or urine, though this is not always necessary in typical cases.
There is no specific antiviral therapy for measles. Management is mainly supportive, focusing on hydration, fever control, and monitoring for complications. The World Health Organization recommends vitamin A supplementation in children, particularly in developing countries, as it reduces morbidity and mortality. Ribavirin may be considered in severe cases among immunocompromised patients. Antibiotics are reserved only for secondary bacterial infections. Post-exposure prophylaxis with immune serum globulin may prevent or attenuate disease in high-risk individuals.
Prevention is primarily achieved through vaccination with the measles-containing vaccine (commonly the MMR vaccine). The standard schedule includes an initial dose at 12–15 months and a booster at 4–6 years. Vaccination has dramatically reduced global incidence, and there is no evidence linking the vaccine to autism. Certain groups, such as pregnant women and severely immunocompromised individuals, should not receive the live vaccine.
The prognosis is generally excellent in healthy individuals, with lifelong immunity following recovery. However, complications are common in vulnerable populations and may include pneumonia, encephalitis, otitis media, severe diarrhea, and blindness. A rare but fatal long-term complication is subacute sclerosing panencephalitis (SSPE), which can occur years after the initial infection.
Measles is a highly contagious viral disease characterized by fever and a distinctive maculopapular rash that begins on the face and spreads downward to the trunk and extremities. The rash is typically preceded by a prodromal phase of cough, coryza, and conjunctivitis, along with the pathognomonic Koplik’s spots on the buccal mucosa. While often self-limited in healthy children, measles remains a major cause of morbidity and mortality, particularly in malnourished or immunocompromised populations.
Globally, measles continues to affect millions of individuals each year, with significant mortality despite widespread vaccination efforts. Although vaccination coverage has improved, outbreaks still occur, especially in low-income countries and in areas affected by conflict or poor healthcare access. Individuals at highest risk include those who are unvaccinated, immunocompromised, pregnant, malnourished, or at extremes of age. Healthcare workers without immunity are also at risk and may contribute to transmission.
The virus spreads via respiratory droplets and initially infects the respiratory mucosa before disseminating through lymphatic and hematogenous routes. It affects multiple organ systems including the skin, conjunctiva, lungs, and gastrointestinal tract. The appearance of the rash corresponds with the host immune response and marks the decline in viral transmissibility. The causative agent is the measles (rubeola) virus, an RNA virus of the Paramyxoviridae family.
Clinically, measles begins with a prodrome of high fever, cough, conjunctivitis, and coryza. Koplik’s spots—small white lesions on the buccal mucosa—appear early and are highly characteristic. This is followed by a red maculopapular rash that starts behind the ears and on the forehead, then spreads downward. The rash typically lasts about five days before fading, sometimes followed by desquamation. In partially immune individuals, atypical and milder presentations may occur.
Diagnosis is primarily clinical, based on characteristic signs and symptoms. Laboratory findings may include leukopenia, T-cell cytopenia, and thrombocytopenia. Serologic testing can confirm diagnosis in atypical cases. Chest imaging may reveal interstitial pneumonitis in severe disease. Viral detection can be performed using immunofluorescence or PCR from respiratory secretions or urine, though this is not always necessary in typical cases.
There is no specific antiviral therapy for measles. Management is mainly supportive, focusing on hydration, fever control, and monitoring for complications. The World Health Organization recommends vitamin A supplementation in children, particularly in developing countries, as it reduces morbidity and mortality. Ribavirin may be considered in severe cases among immunocompromised patients. Antibiotics are reserved only for secondary bacterial infections. Post-exposure prophylaxis with immune serum globulin may prevent or attenuate disease in high-risk individuals.
Prevention is primarily achieved through vaccination with the measles-containing vaccine (commonly the MMR vaccine). The standard schedule includes an initial dose at 12–15 months and a booster at 4–6 years. Vaccination has dramatically reduced global incidence, and there is no evidence linking the vaccine to autism. Certain groups, such as pregnant women and severely immunocompromised individuals, should not receive the live vaccine.
The prognosis is generally excellent in healthy individuals, with lifelong immunity following recovery. However, complications are common in vulnerable populations and may include pneumonia, encephalitis, otitis media, severe diarrhea, and blindness. A rare but fatal long-term complication is subacute sclerosing panencephalitis (SSPE), which can occur years after the initial infection.
- Published on
Infectious Disease and Microbiology - Mastoiditis
Mastoiditis is an infection and inflammation of the mastoid air cells of the temporal bone, typically classified as acute or chronic based on duration. Acute mastoiditis usually follows untreated or inadequately treated middle ear infection, whereas chronic mastoiditis is characterized by persistent ear discharge lasting more than three weeks, often associated with a perforated tympanic membrane.
The incidence of mastoiditis has significantly declined in the antibiotic era due to prompt treatment of otitis media. However, a recent shift toward conservative management of ear infections has led to a slight increase in cases in some regions. It remains a relatively rare condition, with incidence rates ranging from approximately 1.2 to 3.8 cases per 100,000 patient-years. Risk factors include inadequate treatment of otitis media, lack of vaccination against Streptococcus pneumoniae and Haemophilus influenzae, and the presence of cochlear implants.
The disease typically develops as an extension of infection from the middle ear into the mastoid air cells. In acute mastoiditis, the most common causative organisms mirror those of acute otitis media, including Streptococcus pneumoniae, Haemophilus influenzae, Streptococcus pyogenes, and Pseudomonas aeruginosa. Chronic mastoiditis is often polymicrobial, involving organisms such as Pseudomonas aeruginosa, Staphylococcus aureus, gram-negative bacilli, anaerobes, and rarely fungi or mycobacteria.
Clinically, patients often present with symptoms of acute otitis media, including fever, ear pain, and hearing impairment. Physical examination reveals erythema of the tympanic membrane, ear discharge (otorrhea), and characteristic postauricular findings such as swelling, tenderness, and redness over the mastoid region. A key sign is displacement of the pinna outward and downward. In chronic cases, symptoms may be more subtle, including persistent ear discharge and hearing loss.
Diagnosis is supported by laboratory findings such as elevated white blood cell count and inflammatory markers (CRP and ESR). Imaging plays a crucial role, with radiographs showing destruction of mastoid air cell septa and fluid accumulation, while CT or MRI provides detailed assessment of disease extent and complications. Microbiological diagnosis is achieved through culture of ear discharge or middle ear fluid obtained via tympanocentesis.
Management requires prompt and aggressive treatment due to the risk of serious complications. Intravenous antibiotics are the mainstay of therapy, typically using broad-spectrum agents such as third- or fourth-generation cephalosporins, piperacillin-tazobactam, or combinations targeting resistant organisms. Treatment duration is usually 3–4 weeks, with transition to oral therapy after clinical improvement. Chronic mastoiditis may also require local antibiotic therapy and meticulous ear care.
Surgical intervention is indicated in cases of treatment failure, complications, or evidence of bone destruction. Procedures such as mastoidectomy are performed to remove infected tissue and prevent further spread. Less invasive approaches, including drainage and ventilation tube placement, may be considered in selected cases without intracranial involvement.
The prognosis is generally very good when mastoiditis is diagnosed early and treated appropriately. However, delayed or inadequate treatment can lead to serious complications, including subperiosteal abscess, facial nerve paralysis, intracranial infections such as meningitis or brain abscess, and permanent hearing loss.
- Published on
1. Infectious Disease and Microbiology - Malaria
Malaria is a vector-borne parasitic disease transmitted by the bite of an infected female Anopheles mosquito. It is caused by protozoa of the genus Plasmodium and remains one of the most significant global infectious diseases, particularly affecting tropical and subtropical regions. The infection begins when sporozoites are introduced into the bloodstream, subsequently invading liver cells and later red blood cells, leading to systemic illness.
Malaria has a massive global burden, with hundreds of millions of cases annually and millions of deaths, most of which occur in children. It affects over 40% of the world’s population across more than 100 countries. Different species have distinct geographic distributions: Plasmodium falciparum predominates in Africa and is responsible for the most severe disease, while P. vivax, P. ovale, and P. malariae are distributed across other regions. Risk factors include travel to endemic areas, lack of immunity, and, rarely, transmission through blood transfusion or from mother to fetus. Certain genetic traits, such as sickle cell trait, offer partial protection against severe disease.
The pathophysiology involves a complex life cycle between the mosquito and human host. After liver-stage development, parasites invade red blood cells, multiply, and cause their destruction. This leads to hemolysis, release of inflammatory cytokines, and the characteristic febrile illness. P. falciparum is particularly dangerous due to its ability to cause cytoadherence, leading to sequestration of infected red blood cells in small blood vessels, resulting in impaired blood flow and organ dysfunction.
Clinically, malaria presents with nonspecific symptoms such as fever, malaise, headache, and myalgias. A hallmark feature is the malarial paroxysm, consisting of a cold stage with chills, a hot stage with high fever (often exceeding 40°C), and a sweating stage with resolution of fever and profound fatigue. Splenomegaly and tachycardia are common findings. Although fever patterns may be cyclic (tertian or quartan), this periodicity is not always reliable for diagnosis.
Diagnosis is primarily established by microscopic examination of thick and thin blood smears, which allows detection and identification of the parasite species. Rapid diagnostic tests detecting specific antigens are also widely used, especially in resource-limited settings. Laboratory findings often include anemia, thrombocytopenia, and markers of hemolysis. Molecular methods such as PCR can provide confirmation but are not routinely available.
Treatment depends on the species, severity, and drug resistance patterns. Uncomplicated malaria caused by chloroquine-sensitive strains can be treated with chloroquine, while resistant infections require agents such as atovaquone-proguanil, artemisinin-based combinations, or quinine-based regimens. Severe malaria, particularly due to P. falciparum, is a medical emergency requiring intravenous therapy such as artesunate or quinidine, along with intensive supportive care. Monitoring for complications such as hypoglycemia and renal failure is essential.
Preventive strategies focus on reducing mosquito exposure and chemoprophylaxis. Measures include insecticide-treated bed nets, protective clothing, and repellents such as DEET. Travelers to endemic regions may require prophylactic medications depending on resistance patterns. Individuals returning to endemic areas after prolonged absence are at increased risk due to loss of immunity.
The prognosis of malaria depends on early diagnosis and appropriate treatment. Uncomplicated malaria generally responds well to therapy, while untreated P. falciparum infection can lead to severe complications such as cerebral malaria, renal failure, metabolic acidosis, and death. Prompt recognition and management are critical to reducing morbidity and mortality.
Malaria is a vector-borne parasitic disease transmitted by the bite of an infected female Anopheles mosquito. It is caused by protozoa of the genus Plasmodium and remains one of the most significant global infectious diseases, particularly affecting tropical and subtropical regions. The infection begins when sporozoites are introduced into the bloodstream, subsequently invading liver cells and later red blood cells, leading to systemic illness.
Malaria has a massive global burden, with hundreds of millions of cases annually and millions of deaths, most of which occur in children. It affects over 40% of the world’s population across more than 100 countries. Different species have distinct geographic distributions: Plasmodium falciparum predominates in Africa and is responsible for the most severe disease, while P. vivax, P. ovale, and P. malariae are distributed across other regions. Risk factors include travel to endemic areas, lack of immunity, and, rarely, transmission through blood transfusion or from mother to fetus. Certain genetic traits, such as sickle cell trait, offer partial protection against severe disease.
The pathophysiology involves a complex life cycle between the mosquito and human host. After liver-stage development, parasites invade red blood cells, multiply, and cause their destruction. This leads to hemolysis, release of inflammatory cytokines, and the characteristic febrile illness. P. falciparum is particularly dangerous due to its ability to cause cytoadherence, leading to sequestration of infected red blood cells in small blood vessels, resulting in impaired blood flow and organ dysfunction.
Clinically, malaria presents with nonspecific symptoms such as fever, malaise, headache, and myalgias. A hallmark feature is the malarial paroxysm, consisting of a cold stage with chills, a hot stage with high fever (often exceeding 40°C), and a sweating stage with resolution of fever and profound fatigue. Splenomegaly and tachycardia are common findings. Although fever patterns may be cyclic (tertian or quartan), this periodicity is not always reliable for diagnosis.
Diagnosis is primarily established by microscopic examination of thick and thin blood smears, which allows detection and identification of the parasite species. Rapid diagnostic tests detecting specific antigens are also widely used, especially in resource-limited settings. Laboratory findings often include anemia, thrombocytopenia, and markers of hemolysis. Molecular methods such as PCR can provide confirmation but are not routinely available.
Treatment depends on the species, severity, and drug resistance patterns. Uncomplicated malaria caused by chloroquine-sensitive strains can be treated with chloroquine, while resistant infections require agents such as atovaquone-proguanil, artemisinin-based combinations, or quinine-based regimens. Severe malaria, particularly due to P. falciparum, is a medical emergency requiring intravenous therapy such as artesunate or quinidine, along with intensive supportive care. Monitoring for complications such as hypoglycemia and renal failure is essential.
Preventive strategies focus on reducing mosquito exposure and chemoprophylaxis. Measures include insecticide-treated bed nets, protective clothing, and repellents such as DEET. Travelers to endemic regions may require prophylactic medications depending on resistance patterns. Individuals returning to endemic areas after prolonged absence are at increased risk due to loss of immunity.
The prognosis of malaria depends on early diagnosis and appropriate treatment. Uncomplicated malaria generally responds well to therapy, while untreated P. falciparum infection can lead to severe complications such as cerebral malaria, renal failure, metabolic acidosis, and death. Prompt recognition and management are critical to reducing morbidity and mortality.
- Published on
Ophthalmology – Esotropia (Infantile)
Infantile esotropia is a large-angle inward deviation of the eyes that develops within the first 6 months of life in an otherwise healthy infant. It is characterized by a constant deviation typically greater than 35 prism diopters, full ocular motility, and minimal or no significant refractive error. Unlike other forms of esotropia, amblyopia is less common at initial presentation, although it may develop later.
This condition accounts for approximately 8% of all childhood esotropia, with overall esotropia affecting about 2% of children under 6 years. A family history of strabismus is a recognized risk factor.
The underlying pathophysiology is thought to involve abnormal binocular visual development early in life. Studies suggest that disruption of normal sensory input during a critical developmental period leads to persistent ocular misalignment. Early restoration of alignment improves binocular outcomes and reduces later complications.
Infantile esotropia is frequently associated with other ocular motor abnormalities that may develop over time. These include inferior oblique overaction, latent nystagmus, dissociated vertical deviation (DVD), and cross-fixation behavior. Cross-fixation, where the child uses the left eye to look right and vice versa, may simulate an abduction deficit but actually reflects preserved motility.
Parents usually notice eye crossing at birth or within the first few months of life. On examination, there is a large, constant, comitant esotropia with normal ocular structures. Refractive error is typically mild (around +2 diopters, normal for age). Fixation may alternate between eyes; if not, amblyopia should be suspected. Apparent limitation of abduction can often be overcome using cover testing or the Doll’s head maneuver, confirming full extraocular movement.
Neuroimaging is not routinely required, but should be considered if there are abnormal eye movements, atypical features, or significant nystagmus.
The differential diagnosis includes pseudoesotropia, Duane syndrome (Type I), Moebius syndrome, congenital sixth nerve palsy, orbital tumors, and nystagmus blockage syndrome.
Management is primarily surgical, with the goal of achieving early ocular alignment to support binocular vision development. The most common procedure is bilateral medial rectus recession, although larger deviations may require additional muscle surgery. Alignment should ideally be achieved before 24 months of age, and earlier intervention may provide better sensory outcomes.
Before surgery, it is important to treat any amblyopia and correct significant refractive errors to rule out an accommodative component. Although rare, spontaneous resolution can occur, but this is not typically relied upon.
Long-term follow-up is essential. Up to 50% of patients may require additional strabismus surgery by age 10 due to recurrence or development of associated conditions such as inferior oblique overaction or DVD. Patients must also be monitored for amblyopia, refractive errors, and secondary accommodative esotropia.
Parents should be counseled regarding the chronic nature of the condition and the need for ongoing monitoring and possible multiple interventions. If amblyopia persists, protective polycarbonate glasses are recommended.
The prognosis for visual acuity is generally good, with most children achieving normal vision in both eyes. However, stereopsis (depth perception) is often poor unless early alignment is achieved.
Complications include recurrent or consecutive strabismus and amblyopia, both of which may require further treatment.
Infantile esotropia is a large-angle inward deviation of the eyes that develops within the first 6 months of life in an otherwise healthy infant. It is characterized by a constant deviation typically greater than 35 prism diopters, full ocular motility, and minimal or no significant refractive error. Unlike other forms of esotropia, amblyopia is less common at initial presentation, although it may develop later.
This condition accounts for approximately 8% of all childhood esotropia, with overall esotropia affecting about 2% of children under 6 years. A family history of strabismus is a recognized risk factor.
The underlying pathophysiology is thought to involve abnormal binocular visual development early in life. Studies suggest that disruption of normal sensory input during a critical developmental period leads to persistent ocular misalignment. Early restoration of alignment improves binocular outcomes and reduces later complications.
Infantile esotropia is frequently associated with other ocular motor abnormalities that may develop over time. These include inferior oblique overaction, latent nystagmus, dissociated vertical deviation (DVD), and cross-fixation behavior. Cross-fixation, where the child uses the left eye to look right and vice versa, may simulate an abduction deficit but actually reflects preserved motility.
Parents usually notice eye crossing at birth or within the first few months of life. On examination, there is a large, constant, comitant esotropia with normal ocular structures. Refractive error is typically mild (around +2 diopters, normal for age). Fixation may alternate between eyes; if not, amblyopia should be suspected. Apparent limitation of abduction can often be overcome using cover testing or the Doll’s head maneuver, confirming full extraocular movement.
Neuroimaging is not routinely required, but should be considered if there are abnormal eye movements, atypical features, or significant nystagmus.
The differential diagnosis includes pseudoesotropia, Duane syndrome (Type I), Moebius syndrome, congenital sixth nerve palsy, orbital tumors, and nystagmus blockage syndrome.
Management is primarily surgical, with the goal of achieving early ocular alignment to support binocular vision development. The most common procedure is bilateral medial rectus recession, although larger deviations may require additional muscle surgery. Alignment should ideally be achieved before 24 months of age, and earlier intervention may provide better sensory outcomes.
Before surgery, it is important to treat any amblyopia and correct significant refractive errors to rule out an accommodative component. Although rare, spontaneous resolution can occur, but this is not typically relied upon.
Long-term follow-up is essential. Up to 50% of patients may require additional strabismus surgery by age 10 due to recurrence or development of associated conditions such as inferior oblique overaction or DVD. Patients must also be monitored for amblyopia, refractive errors, and secondary accommodative esotropia.
Parents should be counseled regarding the chronic nature of the condition and the need for ongoing monitoring and possible multiple interventions. If amblyopia persists, protective polycarbonate glasses are recommended.
The prognosis for visual acuity is generally good, with most children achieving normal vision in both eyes. However, stereopsis (depth perception) is often poor unless early alignment is achieved.
Complications include recurrent or consecutive strabismus and amblyopia, both of which may require further treatment.
- Published on
Toxicology – Drugs Causing Hyperventilation
Aspirin (Salicylates)
Salicylates directly stimulate the respiratory center in the central nervous system, leading to increased respiratory rate and the development of respiratory alkalosis.
Amphetamines (Speed)
Amphetamines and other sympathomimetic agents elevate catecholamine levels, resulting in increased heart rate, blood pressure, and respiratory rate, often causing hyperventilation.
Paraquat
Paraquat, a toxic herbicide, causes direct lung injury leading to impaired oxygen exchange. This results in hypoxia and compensatory hyperventilation.
Phencyclidine (PCP)
PCP is a dissociative anesthetic that produces minimal cardiopulmonary depression. Patients may fluctuate between sedation and agitation, with hyperventilation commonly occurring during agitated states.
Noncardiogenic Pulmonary Edema (NCPE)
Various toxins can lead to noncardiogenic pulmonary edema, impairing gas exchange and triggering hyperventilation. Inhaled causes include ammonia, chlorine gas, solvents, hydrocarbons, hydrogen sulfide, and phosgene. Oral or parenteral agents include heroin, methadone, naloxone, salicylates, NSAIDs, and certain chemotherapeutic drugs.
Toxin-Induced Metabolic Acidosis
Certain toxins produce metabolic acidosis, which stimulates compensatory hyperventilation (hyperpnea) as the body attempts to reduce carbon dioxide levels and correct acidemia.
Aspirin (Salicylates)
Salicylates directly stimulate the respiratory center in the central nervous system, leading to increased respiratory rate and the development of respiratory alkalosis.
Amphetamines (Speed)
Amphetamines and other sympathomimetic agents elevate catecholamine levels, resulting in increased heart rate, blood pressure, and respiratory rate, often causing hyperventilation.
Paraquat
Paraquat, a toxic herbicide, causes direct lung injury leading to impaired oxygen exchange. This results in hypoxia and compensatory hyperventilation.
Phencyclidine (PCP)
PCP is a dissociative anesthetic that produces minimal cardiopulmonary depression. Patients may fluctuate between sedation and agitation, with hyperventilation commonly occurring during agitated states.
Noncardiogenic Pulmonary Edema (NCPE)
Various toxins can lead to noncardiogenic pulmonary edema, impairing gas exchange and triggering hyperventilation. Inhaled causes include ammonia, chlorine gas, solvents, hydrocarbons, hydrogen sulfide, and phosgene. Oral or parenteral agents include heroin, methadone, naloxone, salicylates, NSAIDs, and certain chemotherapeutic drugs.
Toxin-Induced Metabolic Acidosis
Certain toxins produce metabolic acidosis, which stimulates compensatory hyperventilation (hyperpnea) as the body attempts to reduce carbon dioxide levels and correct acidemia.
- Published on
Ophthalmology – Crohn’s Disease & Ulcerative Colitis (IBD)
Inflammatory bowel disease (IBD), which includes Crohn’s disease (CD) and ulcerative colitis (UC), is a chronic inflammatory condition of the gastrointestinal tract with important extra-intestinal manifestations, including the eye. Ocular involvement can affect nearly all layers of the eye, ranging from mild surface inflammation to severe vision-threatening disease. The most common ophthalmic manifestations include episcleritis, anterior uveitis, scleritis, keratitis, and retinal vasculitis. Although ocular disease is not usually the presenting feature of IBD, it occurs in 3.5–11.8% of patients, with Crohn’s disease generally having more ocular involvement than ulcerative colitis.
The underlying mechanism involves a systemic inflammatory response driven by immune dysregulation in genetically predisposed individuals. This results in infiltration of inflammatory mediators into ocular tissues, leading to edema, tissue damage, and dysfunction. Genetic associations such as HLA-B27 significantly increase the risk of ocular inflammation, particularly acute anterior uveitis. Other associated HLA types include HLA-B58 and HLA-DRB1 variants.
Clinically, symptoms depend on the structure involved. Episcleritis presents with mild redness and irritation without vision loss and often correlates with intestinal disease activity. Anterior uveitis causes pain, photophobia, and blurred vision and may occur independently of bowel disease activity. Scleritis is more severe, presenting with deep, boring pain and tenderness and can threaten vision. Keratitis produces sharp pain and photophobia, while posterior uveitis or retinal vasculitis may lead to blurred vision and retinal complications such as macular edema.
On examination, slit-lamp findings vary by condition. Episcleritis shows superficial redness that blanches with phenylephrine, whereas scleritis shows deeper inflammation that does not blanch and is often tender. Anterior uveitis demonstrates ciliary flush with cells and flare in the anterior chamber. Posterior involvement may reveal vitreous inflammation, vascular sheathing, or macular edema, often requiring imaging such as fluorescein angiography. A B-scan ultrasound may show a characteristic T-sign in posterior scleritis.
Management depends on severity. Episcleritis is usually mild and treated with artificial tears or topical steroids if needed. Anterior uveitis requires intensive topical steroids and cycloplegics. Scleritis often needs systemic therapy such as oral NSAIDs or corticosteroids. More severe or refractory cases—including keratitis and posterior uveitis—may require systemic immunosuppressive therapy such as methotrexate, azathioprine, or anti-TNF agents. Close collaboration with gastroenterology is important, as control of systemic IBD activity helps reduce ocular inflammation.
Follow-up is essential until inflammation resolves. Patients on long-term corticosteroids must be monitored for glaucoma and cataracts, while ongoing inflammation can lead to complications such as macular edema or, rarely, phthisis bulbi. Overall prognosis is generally good, as most patients respond well to treatment, especially when diagnosed early and managed appropriately.
Inflammatory bowel disease (IBD), which includes Crohn’s disease (CD) and ulcerative colitis (UC), is a chronic inflammatory condition of the gastrointestinal tract with important extra-intestinal manifestations, including the eye. Ocular involvement can affect nearly all layers of the eye, ranging from mild surface inflammation to severe vision-threatening disease. The most common ophthalmic manifestations include episcleritis, anterior uveitis, scleritis, keratitis, and retinal vasculitis. Although ocular disease is not usually the presenting feature of IBD, it occurs in 3.5–11.8% of patients, with Crohn’s disease generally having more ocular involvement than ulcerative colitis.
The underlying mechanism involves a systemic inflammatory response driven by immune dysregulation in genetically predisposed individuals. This results in infiltration of inflammatory mediators into ocular tissues, leading to edema, tissue damage, and dysfunction. Genetic associations such as HLA-B27 significantly increase the risk of ocular inflammation, particularly acute anterior uveitis. Other associated HLA types include HLA-B58 and HLA-DRB1 variants.
Clinically, symptoms depend on the structure involved. Episcleritis presents with mild redness and irritation without vision loss and often correlates with intestinal disease activity. Anterior uveitis causes pain, photophobia, and blurred vision and may occur independently of bowel disease activity. Scleritis is more severe, presenting with deep, boring pain and tenderness and can threaten vision. Keratitis produces sharp pain and photophobia, while posterior uveitis or retinal vasculitis may lead to blurred vision and retinal complications such as macular edema.
On examination, slit-lamp findings vary by condition. Episcleritis shows superficial redness that blanches with phenylephrine, whereas scleritis shows deeper inflammation that does not blanch and is often tender. Anterior uveitis demonstrates ciliary flush with cells and flare in the anterior chamber. Posterior involvement may reveal vitreous inflammation, vascular sheathing, or macular edema, often requiring imaging such as fluorescein angiography. A B-scan ultrasound may show a characteristic T-sign in posterior scleritis.
Management depends on severity. Episcleritis is usually mild and treated with artificial tears or topical steroids if needed. Anterior uveitis requires intensive topical steroids and cycloplegics. Scleritis often needs systemic therapy such as oral NSAIDs or corticosteroids. More severe or refractory cases—including keratitis and posterior uveitis—may require systemic immunosuppressive therapy such as methotrexate, azathioprine, or anti-TNF agents. Close collaboration with gastroenterology is important, as control of systemic IBD activity helps reduce ocular inflammation.
Follow-up is essential until inflammation resolves. Patients on long-term corticosteroids must be monitored for glaucoma and cataracts, while ongoing inflammation can lead to complications such as macular edema or, rarely, phthisis bulbi. Overall prognosis is generally good, as most patients respond well to treatment, especially when diagnosed early and managed appropriately.
